Home

Kristen Ambrose, SVP & Chief Accounting Officer: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/13

Trade details

Type
Insider sale
Amount
$577,409.76
Shares · price
1,374 sh · $420.24 a share
Held after
9,676 sh
Trade date
24/02/12
Filed
24/02/13
Days to filing
1 days

Sold 12.4% of holdings

Share of holding sold
12.4%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Kristen Ambrose's recent trades

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $172.6K

    Filed 03/02

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $108.5K

    Filed 02/26

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $762.1K

    Filed 02/19

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $302.2K

    Filed 02/19

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $633.6K

    Filed 02/12